Search

The commercial imperative is undermining basic research and threatening the university ethos according to an independent body, says a new report.

The Alsace BioValley cluster has launched SHIP-In, a project to develop induced pluripotent stem cells for use in drug discovery.

The UK Technology Strategy Board (TSB) will invest £39.5 million across six calls in the next six months, in areas from regenerative medicine to low carbon housing.

Microsoft and Tilburg University in the Netherlands have entered into a four-year agreement in which Microsoft will support the research of the Tilburg Law and Economics Centre.

A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.